Bleakley Financial Group LLC Has $545,000 Stake in Agilent Technologies, Inc. (NYSE:A)
Bleakley Financial Group LLC trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 92.2% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,536 shares of the medical research company’s stock after selling 53,838 shares during the period. Bleakley Financial Group LLC’s holdings in Agilent Technologies were worth $545,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of A. Hollencrest Capital Management grew its stake in Agilent Technologies by 562.5% during the second quarter. Hollencrest Capital Management now owns 212 shares of the medical research company’s stock worth $25,000 after buying an additional 180 shares in the last quarter. Money Concepts Capital Corp acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $26,000. Clearstead Trust LLC acquired a new stake in shares of Agilent Technologies in the 2nd quarter valued at approximately $30,000. Glass Jacobson Investment Advisors llc acquired a new stake in shares of Agilent Technologies in the 2nd quarter valued at approximately $32,000. Finally, Bogart Wealth LLC boosted its stake in shares of Agilent Technologies by 80.7% in the 2nd quarter. Bogart Wealth LLC now owns 271 shares of the medical research company’s stock valued at $33,000 after purchasing an additional 121 shares in the last quarter. 85.42% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Agilent Technologies
In other news, CEO Michael R. Mcmullen sold 62,467 shares of the firm’s stock in a transaction that occurred on Thursday, December 7th. The shares were sold at an average price of $130.00, for a total transaction of $8,120,710.00. Following the completion of the sale, the chief executive officer now owns 306,206 shares of the company’s stock, valued at approximately $39,806,780. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.31% of the company’s stock.
Agilent Technologies Stock Down 1.2 %
Agilent Technologies stock opened at $127.20 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.97 and a current ratio of 2.61. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $160.26. The firm has a 50 day moving average price of $114.00 and a two-hundred day moving average price of $117.54. The firm has a market cap of $37.22 billion, a price-to-earnings ratio of 30.21, a PEG ratio of 2.94 and a beta of 1.10.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings data on Monday, November 20th. The medical research company reported $1.38 EPS for the quarter, topping the consensus estimate of $1.34 by $0.04. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 18.15% and a return on equity of 28.24%. The company’s quarterly revenue was down 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.53 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.47 EPS for the current year.
Agilent Technologies Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be given a dividend of $0.236 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.23. The ex-dividend date is Friday, December 29th. This represents a $0.94 annualized dividend and a dividend yield of 0.74%. Agilent Technologies’s dividend payout ratio (DPR) is 22.33%.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on A. UBS Group downgraded shares of Agilent Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the company from $163.00 to $125.00 in a research note on Friday, November 17th. TD Cowen raised their price target on shares of Agilent Technologies from $145.00 to $147.00 and gave the company an “outperform” rating in a research note on Wednesday, August 16th. Jefferies Financial Group reduced their price target on shares of Agilent Technologies from $150.00 to $146.00 and set a “buy” rating on the stock in a research note on Wednesday, August 16th. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $160.00 to $145.00 and set an “overweight” rating for the company in a report on Wednesday, November 22nd. Finally, Credit Suisse Group dropped their price objective on shares of Agilent Technologies from $160.00 to $150.00 and set an “outperform” rating for the company in a report on Wednesday, August 16th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $138.13.
Get Our Latest Stock Analysis on Agilent Technologies
Agilent Technologies Company Profile (Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Agilent Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Agilent Technologies wasn’t on the list.
While Agilent Technologies currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Click the link below and we’ll send you MarketBeat’s list of seven best retirement stocks and why they should be in your portfolio.